Habiba Umm E, Nazar Netasha, Fatima Kashaf, Rehman Asad Ur, Ashraf Aneeqa, Kouser Mamoona, Alfardan Noor, Yusuf Yusuf, Islam Maryyam
Obstetrics and Gynecology, District Headquarters (DHQ) Hospital Okara, Okara, PAK.
Obstetrics and Gynecology, Lady Willingdon Hospital, Lahore, PAK.
Cureus. 2025 Apr 10;17(4):e81984. doi: 10.7759/cureus.81984. eCollection 2025 Apr.
Uterine fibroids are common benign tumors that can cause significant symptoms such as heavy bleeding, pelvic pain, and reproductive issues.
The aim of this study was to evaluate the clinical patterns, treatment modalities, and patient outcomes associated with uterine fibroids.
This retrospective study was conducted at DHQ Hospital Okara, Okara, Pakistan, from June 2024 to December 2024. Data were collected from the medical records of 355 patients diagnosed with symptomatic uterine fibroids. Women who had confirmed uterine fibroids diagnosed through ultrasound were included in the study. Women who received treatment for uterine fibroids and patients with incomplete medical records were excluded from the study. Data were collected from medical records. The demographic information included age, marital status, parity, and reproductive history.
The majority of patients were aged between 35 and 50 years (69.9%), with a mean age of 41.2 ± 7.83 years. Most patients were premenopausal (231, 65%) and multiparous (266, 74.9%). The most common symptoms were menorrhagia (248, 69.9%) and pelvic pain (195, 54.9%). The most frequent treatment modality was hormonal therapy (142, 40%), followed by surgical management (89, 25.1%) and minimally invasive procedures (53, 14.9%). Symptom improvement was highest in the minimally invasive group (92, 80%), while surgical treatments showed high patient satisfaction (64, 90%).
It is concluded that the treatment of uterine fibroids is largely influenced by factors such as age, fibroid size, and the severity of symptoms.
子宫肌瘤是常见的良性肿瘤,可导致大量出血、盆腔疼痛和生殖问题等显著症状。
本研究旨在评估与子宫肌瘤相关的临床模式、治疗方式及患者预后。
本回顾性研究于2024年6月至2024年12月在巴基斯坦奥卡拉的DHQ医院进行。数据收集自355例诊断为有症状子宫肌瘤患者的病历。经超声确诊有子宫肌瘤的女性纳入研究。接受过子宫肌瘤治疗的女性及病历不完整的患者被排除在研究之外。数据从病历中收集。人口统计学信息包括年龄、婚姻状况、产次和生殖史。
大多数患者年龄在35至50岁之间(69.9%),平均年龄为41.2±7.83岁。大多数患者处于绝经前(231例,65%)且为经产妇(266例,74.9%)。最常见的症状是月经过多(248例,69.9%)和盆腔疼痛(195例,54.9%)。最常用的治疗方式是激素治疗(142例,40%),其次是手术治疗(89例,25.1%)和微创手术(53例,14.9%)。症状改善在微创组最高(92例,80%),而手术治疗显示出较高的患者满意度(64例,90%)。
得出结论,子宫肌瘤的治疗在很大程度上受年龄、肌瘤大小和症状严重程度等因素影响。